Jefferies upgrade puts Chagee back in focus ahead of November print

CHA heads into the week with a fresh analyst upgrade, a doubling of short interest over the past month, and earnings on the horizon, three threads that don't yet point in the same direction.

The most immediate development is the Jefferies move. This morning, analyst Lisa Liao upgraded Chagee to Buy from Hold and lifted the price target to $14.90 from $11.80, a 26% increase in the target on a stock trading at $12.48. That upgrade arrives against a backdrop of modest price action: CHA gained 1.1% on Tuesday and is roughly flat on the week, up just over 4% on the month. JP Morgan has had an Overweight rating in place since April, with a $16 target, so the Jefferies upgrade brings the two most recently active major-firm analysts into alignment on direction, even if their targets differ. CLSA sits more cautiously at Hold, with a $10 target set back in June.

The note worth flagging is the gap between where the stock trades and the mean price target of $102. That figure almost certainly reflects stale or mismatched data from early initiations, and should not be taken at face value. The Jefferies $14.90 and JP Morgan's $16 are the live reference points.

Short interest has more than doubled over the past month, rising around 107%, though in absolute terms the position remains modest. Roughly 1.93 million shares are short, and the lending market is anything but strained: availability is running at over 2,000%, meaning there are more than 20 shares available to borrow for every one currently borrowed. Cost to borrow has been volatile, jumping from 0.66% on October 16 to 1.71% on October 20, a 63% weekly rise, but the absolute level remains low. Utilization is just 5.5%, well off the 100% reading touched earlier in the year. The borrow market, in short, is loose. The doubling of short interest is worth watching, but it has not yet created any squeeze dynamic.

The fundamental picture looks more interesting than the price might suggest. Chagee's EPS surprise factor ranks in the 98th percentile of the ORTEX universe, and forward earnings growth expectations are extreme: a prior stock-score note flagged a 2,943% year-on-year increase in forward EPS estimates embedded in consensus, reflecting a sharp recovery from a low base. The EV/EBITDA multiple is undemanding at 3.8x, and the PE ratio of 7.7x leaves room for re-rating if the growth trajectory holds. The dividend yield factor scores in the 81st percentile. Value is not the objection here; execution is.

Ownership is tightly held. Founder Junjie Zhang controls around 34% of shares, XVC holds nearly 18%, and Shenzhen Congbi Qiushi another 9%. Between the three largest holders, more than 60% of the company is locked up. On the institutional side, BlackRock added 833,000 shares in the June quarter, while Citadel and Point72 both built new or significantly enlarged positions, each adding over 700,000 shares. Fosun trimmed its stake and now sits at 3.1%. The insider filings on record are all transaction-code A (awards and grants), not open-market purchases, so they carry limited conviction signal. All recent insider activity has zero disclosed price or value.

The next earnings print is scheduled for November 27. CHA's only recorded earnings reaction saw the stock jump 12.4% on the day and hold those gains through the following week, so the market has rewarded a beat before. The question going into that date is whether the forward EPS recovery story, which underpins both the Jefferies upgrade and the extreme growth factor score, translates into a result that matches expectations now being set.